Mar 18 |
Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion
|
Mar 17 |
15 Highest Quality Probiotics For Gut Health
|
Mar 5 |
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion
|
Feb 28 |
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
|
Feb 28 |
Oragenics Announces Pricing of Public Offering
|
Feb 27 |
Oragenics to sell shares in a public offering
|
Feb 27 |
Oragenics Announces Proposed Public Offering
|
Feb 12 |
Oragenics says CEO Murphy steps down from the role
|
Feb 12 |
Oragenics, Inc. Announces Leadership Transition
|
Feb 7 |
Oragenics, Inc. Announces Expiration of Its Investment Banking Engagement Agreement
|